US Patent

US7749194 — Devices, systems, and methods for medicament delivery

Formulation · Assigned to Intelliject Inc · Expires 2028-10-30 · 2y remaining

Vulnerability score 60/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects devices, systems, and methods for delivering injectable medicaments, including a vial and housing auto-injector design.

USPTO Abstract

Certain exemplary embodiments comprise can comprise an auto-injector, which can comprise: a vial configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection.

Drugs covered by this patent

Patent Metadata

Patent number
US7749194
Jurisdiction
US
Classification
Formulation
Expires
2028-10-30
Drug substance claim
No
Drug product claim
Yes
Assignee
Intelliject Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.